New hope for rare blood cancer: experimental drug faces final test
NCT ID NCT06561048
First seen Mar 16, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This study tests a new drug called soquelitinib against standard treatments for people with a rare blood cancer (peripheral T-cell lymphoma) that has returned or not responded to prior therapy. About 150 adults will be randomly assigned to receive either soquelitinib or a standard single-drug treatment chosen by their doctor. The main goal is to see if soquelitinib can delay cancer growth or improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Hospital
RECRUITINGHeidelberg, Victoria, 3084, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
BC Cancer Research Institute
RECRUITINGVancouver, British Columbia, V5Z4E6, Canada
-
Box Hill Hospital
RECRUITINGBox Hill, Victoria, 3128, Australia
Contact Email: •••••@•••••
Contact
-
City of Hope National Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Epworth Healthcare
RECRUITINGRichmond, Victoria, 3121, Australia
Contact Email: •••••@•••••
-
Flinders Medical Center
RECRUITINGBedford Park, South Australia, 5042, Australia
Contact
Contact Email: •••••@•••••
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
ICON Cancer Centre
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
Contact Email: •••••@•••••
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Linear Clinical Research
RECRUITINGPerth, Western Australia, 6009, Australia
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Email: •••••@•••••
Contact
-
North Carolina Cancer Hospital
RECRUITINGChapel Hill, North Carolina, 27514, United States
Contact
Contact Email: •••••@•••••
-
North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
Contact
-
Roger Cancer Center University of Michigan Health
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Email: •••••@•••••
Contact
-
Royal Hobart Hospital
RECRUITINGHobart, Tasmania, 7000, Australia
Contact
Contact Email: •••••@•••••
-
St George Hospital
RECRUITINGKogarah, New South Wales, 2217, Australia
Contact Email: •••••@•••••
-
St Vincent's Hospital Sydney
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-••••
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Ottawa Hospital - General Campus
RECRUITINGOttawa, Ontario, K1H8L6, Canada
-
The Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G2C4, Canada
Contact
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
Contact
-
University of California, Irvine
RECRUITINGIrvine, California, 92697, United States
Contact Email: •••••@•••••
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Maryland Medical Center
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Washington Fred Hutch Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
Contact Email: •••••@•••••
Contact
-
University of Wisconsin Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53792, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University in St. Louis
RECRUITINGSt Louis, Missouri, 63130, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
Contact
Contact Email: •••••@•••••
-
Yale University
RECRUITINGNew Haven, Connecticut, 06520, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.